Latest News

Q3 2026 Earnings Snapshot Cintas (CTAS) has just reported Q3 2026 results with quarterly revenue of about US$2.8b and basic EPS of US$1.23, giving investors a fresh read on how the business is tracking this year. Over recent quarters the company has seen revenue move from US$2.50b in Q1 2025 to US$2.80b in Q2 2026, while basic EPS has shifted from US$1.12 to US$1.23, with trailing twelve month net profit margins around 17.5% helping to frame the quality of those earnings. See our full...

Daktronics (DAKT) is back in the spotlight after announcing three fresh major league baseball projects, including a new Mariners Fire TV outfield board in Seattle and large center field displays in Phoenix and Chicago. See our latest analysis for Daktronics. The recent major league baseball wins sit against a mixed share price backdrop, with a 7 day share price return of 5.88%, a 30 day share price return of 22.11% and a 1 year total shareholder return of 69.73%. This indicates that longer...

Epsilon Energy (EPSN) has just posted its FY 2025 numbers with third quarter revenue of about US$9.0 million and basic EPS of US$0.05, set against trailing twelve month revenue of US$45.7 million and EPS of US$0.27 that came alongside 11.2% earnings growth and a trailing net margin of 12.9% compared with 17% a year earlier. Over recent quarters the company has seen revenue move from US$7.3 million in Q2 2024 to US$16.2 million in Q1 2025, then to US$9.0 million in Q3 2025. Quarterly EPS has...

BioStem Technologies (OTCPK:BSEM) appointed Jodi Ungrodt as a new member of its Board of Directors and Chair of the Audit Committee. The company completed the acquisition of BioTissue Holdings Inc.'s surgical and wound assets, including a national sales force. The transaction expands BioStem's commercial reach into hospital settings and broadens its product portfolio. BioStem Technologies, trading at $4.92, sits at an interesting point in its share price history, with a 25.9% return year to...

Zhihu (NYSE:ZH) has posted a mixed FY 2025 update, with Q3 revenue at C¥658.9 million and basic EPS of C¥0.58 loss per share, while trailing 12 month figures show revenue of C¥2.97 billion and basic EPS of C¥1.25. Over recent quarters, revenue has shifted from C¥933.8 million in Q2 2024 to C¥859.2 million in Q4 2024, then to C¥716.9 million in Q2 2025 and C¥658.9 million in Q3 2025. Net income moved from a C¥82.7 million loss in Q2 2024 to a C¥72.5 million profit in Q2 2025, before a C¥46.7...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Vt Holdings Co.,Ltd. ( TSE:7593 ) stock is about to trade ex-dividend in three days. The ex-dividend date is usually...

Glass House Brands (OTCPK:GLAS.F) has just posted a mixed FY 2025 picture, with Q3 revenue of US$38.4 million and a basic EPS loss of US$0.19, set against trailing 12 month revenue of US$196.2 million and a basic EPS loss of US$0.23. Over recent quarters, the company has seen revenue range from US$53.0 million in Q4 2024 to US$59.9 million in Q2 2025, while basic EPS has swung between a profit of US$0.10 in Q4 2024 and a loss of US$0.19 in Q3 2025. This keeps the focus firmly on how...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Inspire Medical Systems (NYSE:INSP) has put forward a proposal to amend its Certificate of Incorporation. Shareholders are scheduled to vote on the amendment at the upcoming annual general meeting. The change targets the company’s core governance framework, which may influence how future decisions are approved and overseen. The vote comes at a time when Inspire Medical Systems shares trade around $51.41, with returns showing an 8.8% decline over the past week and 11.8% over the past month...

Prosperity Real Estate Investment Trust (SEHK:808) has released its FY 2025 numbers with first half revenue of HK$205.8 million and basic EPS of HK$0.11 loss per unit, while the trailing twelve months point to revenue of HK$408.5 million and basic EPS of HK$0.16 loss. Over the past few reporting periods, the trust has seen revenue move from HK$214.9 million in 1H FY 2024 to HK$210.4 million in 2H FY 2024 and then to HK$205.8 million in 1H FY 2025, alongside basic EPS shifting between a...

Braze (BRZE) just closed out FY 2026 with fourth quarter revenue of US$205.2 million and a basic EPS loss of US$0.29, while the trailing twelve months show revenue of US$738.2 million and a full year basic EPS loss of US$1.22. Over recent periods, the company has seen quarterly revenue move from US$160.4 million in Q4 FY 2025 to US$205.2 million in Q4 FY 2026, with basic EPS losses in those quarters of US$0.17 and US$0.29 respectively. With losses still weighing on margins, the latest numbers...

Velo3D (VELO) has released its latest FY 2025 figures, reporting Q3 revenue of US$13.6 million and a basic EPS loss of US$0.69, alongside net income excluding extra items of a US$11.8 million loss. This keeps the focus firmly on profitability rather than the top line alone. Over recent quarters, the company’s revenue moved from US$8.2 million in Q3 2024 to US$13.6 million in Q3 2025, while basic EPS shifted from a loss of US$37.54 to a loss of US$0.69 as net losses moved from US$23.1 million...

Cosmo Energy Holdings Co., Ltd. ( TSE:5021 ) shareholders will have a reason to smile today, with the analysts making...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Astellas...

Nitori Holdings Co., Ltd. ( TSE:9843 ) stock is about to trade ex-dividend in four days. The ex-dividend date generally...

SD Biosensor, Inc. ( KRX:137310 ) is about to trade ex-dividend in the next four days. Typically, the ex-dividend date...

Readers hoping to buy Square Enix Holdings Co., Ltd. ( TSE:9684 ) for its dividend will need to make their move...

Noah Holdings (NYSE:NOAH) has wrapped up FY 2025 with fourth quarter revenue of C¥733.2 million and net income, excluding extra items, of C¥12.8 million, setting the stage for investors to reassess the story at a share price of US$11.33. Over the past few quarters, the company has seen quarterly revenue move from C¥651.9 million in Q4 2024 to C¥614.6 million, C¥629.5 million and C¥632.9 million in the first three quarters of 2025. Over the same period, basic EPS stepped from C¥1.56 in Q4 2024...

EDAP TMS (NasdaqGM:EDAP) has reported Q3 2025 revenue of €13.9 million, with a basic EPS loss of €0.13 and net income loss of €5.0 million, while the trailing twelve months show revenue of €63.8 million, basic EPS loss of €0.52 and a net income loss of €19.6 million. Over recent quarters, the company has reported revenue of €13.1 million in Q3 2024, €20.3 million in Q4 2024 and €16.0 million in Q2 2025. Quarterly EPS losses have ranged from €0.05 in Q4 2024 to €0.19 in Q1 2025. This...

Waterdrop (NYSE:WDH) has put solid numbers on the table for FY 2025 so far, with third quarter revenue of ¥974.9 million and basic EPS of ¥0.44, alongside trailing 12 month EPS of ¥1.40 supported by net income of ¥506.4 million on revenue of ¥3.25 billion. Over recent quarters the company has seen revenue move from ¥676.2 million in Q2 2024 to ¥753.7 million in Q1 2025 and then to ¥974.9 million in Q3 2025. Basic EPS progressed from ¥0.24 in Q2 2024 to ¥0.30 in Q1 2025 and ¥0.44 in Q3 2025,...

The U.S. FDA has issued a warning letter to ImmunityBio over allegedly false and misleading promotional claims for its bladder cancer drug Anktiva. The letter focuses on how Anktiva has been marketed to healthcare professionals and patients, and requests corrective action from the company. This regulatory action introduces additional marketing and compliance risk for ImmunityBio at a time when its drug portfolio is gaining wider attention. For investors following ImmunityBio, ticker...

As you might know, China Resources Beer (Holdings) Company Limited ( HKG:291 ) last week released its latest yearly...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see LG...